|
Carcinoma, Neuroendocrine
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Herein, we report two cases of lung neuroendocrine carcinoma with carcinoid morphology that correspond to NET G3.
|
31511024 |
2019 |
|
Carcinoma, Neuroendocrine
|
0.100 |
Biomarker
|
disease |
BEFREE |
No PAX5 cytoplasmic staining was seen in all grades of NET in other organs, rectal WD-NET G3, and all neuroendocrine carcinoma.
|
29561272 |
2019 |
|
Carcinoma, Neuroendocrine
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
In this study, APOBEC3B is highly expressed in GEP-NETs and is a predictor of lymph node metastasis in NET G3 and NEC cases.
|
30095460 |
2019 |
|
Carcinoma, Neuroendocrine
|
0.100 |
Biomarker
|
disease |
BEFREE |
NET G3 are considered a molecularly, radiologically, and prognostically distinct entity compared to NEC and NET G1/G2.
|
31428952 |
2019 |
|
Carcinoma, Neuroendocrine
|
0.100 |
Biomarker
|
disease |
BEFREE |
No prognostic difference was detected between NET G3 and NEC patients after 5 year DFS.
|
31422400 |
2019 |
|
Carcinoma, Neuroendocrine
|
0.100 |
Biomarker
|
disease |
BEFREE |
A sharp distinction between NET and poorly differentiated neuroendocrine carcinoma (NEC) is emphasized to highlight substantial biological differences.
|
30098710 |
2018 |
|
Carcinoma, Neuroendocrine
|
0.100 |
Biomarker
|
disease |
BEFREE |
The major categories of pancreatic neuroendocrine tumor (PanNET) are well-differentiated NET and poorly differentiated neuroendocrine carcinoma.
|
29521944 |
2018 |
|
Carcinoma, Neuroendocrine
|
0.100 |
Biomarker
|
disease |
BEFREE |
Seventy-two patients were pathologically diagnosed as neuroendocrine tumor G1 (NET G1), 48 as neuroendocrine tumor G2 (NET G2) and 30 as neuroendocrine carcinoma G3 (NEC G3).
|
29307515 |
2018 |
|
Carcinoma, Neuroendocrine
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Pancreatic neuroendocrine neoplasms (pNENs) are rare tumors accounting for only 1%-2% of all pancreatic tumors. pNENs are pathologically heterogeneous and are categorized into three groups (neuroendocrine tumor: NET G1, NET G2; and neuroendocrine carcinoma: NEC) on the basis of the Ki-67 proliferation index and the mitotic count according to the 2010 World Health Organization (WHO) classification of gastroenteropancreatic NENs.
|
28098761 |
2017 |
|
Carcinoma, Neuroendocrine
|
0.100 |
Biomarker
|
disease |
BEFREE |
Clinicopathologic correlation was made among poorly differentiated neuroendocrine carcinomas (NECs/poorly differentiated histology and Ki-67 >20%) and pancreatic neuroendocrine tumours (PanNETs/Ki67 ⩽20%) and non-pancreatic neuroendocrine tumours (NP-NETs/Ki67 ⩽20%).
|
27482646 |
2016 |